STOCK TITAN
  1. Home
  2. Sec-filings
  3. XYL
  4. [Form 4] Xylem Inc. Insider Trading Activity

Xylem insider Form 4: 10,421 shares sold at $152.64 avg

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Xylem Inc. (XYL) reported an insider transaction by EVP, CPSO Claudia S. Toussaint. On 10/30/2025, a revocable trust for which she is trustee sold 10,421 shares of common stock at a weighted average price of $152.64, with executions ranging from $152.51 to $152.98. Following the sale, the filing shows 31,250 shares indirectly owned by the Claudia S. Toussaint Revocable Trust and 3,939 shares directly owned.

Positive

  • None.

Negative

  • None.
Insider Toussaint Claudia S
Role EVP, CPSO
Sold 10,421 shs ($1.59M)
Type Security Shares Price Value
Sale Common Stock 10,421 $152.64 $1.59M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 31,250 shares (Indirect, by Claudia S. Toussaint Revocable Trust); Common Stock — 3,939 shares (Direct)
Footnotes (1)
  1. Reflects the sale of shares of common stock from the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 10,421 Shares were executed at a range of prices from $152.51 to $152.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Toussaint Claudia S
(Last) (First) (Middle)
C/O XYLEM INC.
301 WATER STREET SE
(Street)
WASHINGTON DC 20003
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CPSO
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2025 S 10,421(1) D $152.64(2) 31,250 I by Claudia S. Toussaint Revocable Trust
Common Stock 3,939 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects the sale of shares of common stock from the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.
2. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 10,421 Shares were executed at a range of prices from $152.51 to $152.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
/s/ Mike Nazario, by power of attorney for Claudia S. Toussaint 10/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Xylem (XYL) disclose?

A Form 4 reports the sale of 10,421 shares of common stock by a revocable trust associated with EVP, CPSO Claudia S. Toussaint on 10/30/2025.

What was the sale price for the Xylem (XYL) shares?

The filing states a weighted average price of $152.64, with individual trades executed between $152.51 and $152.98.

How many Xylem (XYL) shares does the reporting person hold after the sale?

The filing shows 31,250 shares indirectly owned by the trust and 3,939 shares directly owned.

Who executed the sale for Xylem (XYL)?

Shares were sold by the Claudia S. Toussaint Revocable Trust, of which the reporting person is trustee; she and her immediate family are sole beneficiaries.

What is the reporter’s role at Xylem (XYL)?

The reporting person is an Officer with the title EVP, CPSO.